Skip to content

MS Mosaic: A Longitudinal Research Study on Multiple Sclerosis

MS Mosaic: A Longitudinal Research Study on Multiple Sclerosis

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02845635
Enrollment
2200
Registered
2016-07-27
Start date
2017-09-29
Completion date
2021-07-28
Last updated
2022-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple Sclerosis

Brief summary

The purpose of this study is to better characterize the fluctuations in multiple sclerosis symptoms and their relationship to medications, to length/extent of disease, and to a variety of physiologic measures.

Interventions

OTHERPersonal history of multiple sclerosis

Participants will be stratified into one of four cohorts based on their experience (or lack of experience) with the three major forms of multiple sclerosis.

Sponsors

Duke University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Be at least 18 years old * Live in the United States of America * Read/write in English

Exclusion criteria

* None

Design outcomes

Primary

MeasureTime frameDescription
Change in perceived fatigue severity (self-report) as recorded by symptom diaryEvery 24 hours through study completion, an average of 6 months
Change in perceived cognitive impairment (self-report) as recorded by symptom diaryEvery 24 hours through study completion, an average of 6 monthsSeverity of cognitive impairment experienced from multiple sclerosis
Change in perceived depression or anxiety severity (self-report) as recorded by symptom diaryEvery 24 hours through study completion, an average of 6 monthsSeverity of any mood disorders experienced from multiple sclerosis

Secondary

MeasureTime frameDescription
Change in perceived sensory disturbance (self-report) as recorded by symptom diaryEvery 24 hours through study completion, an average of 6 months
Change in perceived vertigo severity (self-report) as recorded by symptom diaryEvery 24 hours through study completion, an average of 6 months
Change in perceived dysarthria severity (self-report) as recorded by symptom diaryEvery 24 hours through study completion, an average of 6 months
Change in pain (self-report) as recorded by symptom diaryEvery 24 hours through study completion, an average of 6 months
Change in perceived walking instability (self-report) as recorded by symptom diaryEvery 24 hours through study completion, an average of 6 months
Change in medication adherence (self-report) as recorded by medication diaryEvery 24 hours through study completion, an average of 6 months
Change in self-efficacy (self-report) as determined by the Multiple Sclerosis self-efficacy scale (survey instrument)every three months, through study completion (an average of 6 months)
Change in Multiple Sclerosis Quality of Life Inventoryprompted based on the app user's responses on the daily surveys, up to 6 monthsThe Multiple Sclerosis Quality of Life Inventory surveys are prompted based on the app user's responses on the daily surveys.
Change in sleep quality as recorded by app-linked wearable deviceEvery 24 hours through study completion, an average of 6 months
Change in perceived vision difficulties (self-report) as recorded by symptom diaryEvery 24 hours through study completion, an average of 6 months
Change in perceived Bowel/Bladder dysfunction (self-report) as recorded by symptom diaryEvery 24 hours through study completion, an average of 6 monthsSeverity of bowel/bladder dysfunction experienced from multiple sclerosis

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026